Table 1:
Demographic, socio-behavioural and clinical characteristics of participants screened positive for depression or substance use (n=753)
| Characteristics | N (%) |
|---|---|
| Total | 753 (100) |
| Age at survey (years) | Median = 38, IQR (31–47) |
| ≤30 | 188 (25) |
| 31–40 | 239 (32) |
| 41–50 | 216 (29) |
| >50 | 110 (15) |
| Sex | |
| Male | 678 (90) |
| Female | 75 (10) |
| HIV mode of exposure | |
| Heterosexual contact | 233 (31) |
| MSM | 406 (54) |
| Injecting drug use | 13 (2) |
| Other/Unknown | 101 (13) |
| Viral load at recruitment (copies/mL) | Median = 33, IQR (19–39) |
| <50 | 455 (60) |
| 50–399 | 32 (4) |
| 400–999 | 3 (0) |
| ≥1000 | 43 (6) |
| Not tested | 220 (29) |
| CD4 count at recruitment (cells/μL) | Median = 518, IQR (324–725) |
| ≤200 | 63 (8) |
| 201–350 | 86 (11) |
| 351–500 | 103 (14) |
| >500 | 276 (37) |
| Not tested | 225 (30) |
| Current ART | |
| NRTI+NNRTI | 387 (51) |
| NRTI+PI | 51 (7) |
| INSTI | 270 (36) |
| Other | 24 (3) |
| None/unknown | 21 (3) |
| Hepatitis B co-infection | |
| Negative | 250 (33) |
| Positive | 27 (4) |
| Not tested | 476 (63) |
| Hepatitis C co-infection | |
| Negative | 343 (46) |
| Positive | 26 (3) |
| Not tested | 384 (51) |
| Prior AIDS Diagnosis | |
| No | 476 (63) |
| Yes | 176 (23) |
| Not reported | 101 (13) |
| House hold income (USD) per month | |
| ≤$500 | 184 (14) |
| $501-$2000 | 215 (29) |
| >$2000 | 233 (31) |
| Not reported/unknown | 121 (16) |
| Employment | |
| No | 159 (21) |
| Full time | 426 (57) |
| Part time | 113 (15) |
| Not reported/unknown | 55 (7) |
| Highest education level | |
| No education | 3 (0) |
| Primary to high school | 235 (31) |
| College to university | 497 (66) |
| Not reported/unknown | 18 (2) |
| HIV disclosure status | |
| Fully | 37 (5) |
| Partially | 538 (71) |
| Not disclosed | 140 (19) |
| Not reported/unknown | 38 (5) |
| Previous stressors | |
| No | 301 (40) |
| Yes | 399 (53) |
| Not reported/unknown | 53 (7) |
| Family history of mental health disorder | |
| No | 637 (85) |
| Yes | 32 (4) |
| Not reported/unknown | 84 (11) |
| Comorbidities | |
| No | 302 (40) |
| Yes | 130 (17) |
| Not reported/unknown | 321 (43) |
| Previous mental health disorder | |
| No | 539 (72) |
| Yes | 61 (8) |
| Not reported/unknown | 153 (20) |
| History of STIs in the past 5 years | |
| No | 339 (45) |
| Yes | 237 (31) |
| Not reported/unknown | 177 (24) |
| Year of ART initiation | |
| <2010 | 199 (26) |
| 2010–2012 | 98 (13) |
| 2013–2015 | 160 (21) |
| 2016–2020 | 286 (38) |
| No ART/unknown | 10 (1) |
| ART adverse events in the previous year | |
| No | 510 (68) |
| Yes | 80 (11) |
| Not reported/unknown | 163 (22) |
| ART adherence in the previous year | |
| ≥95 | 479 (64) |
| <95 | 52 (7) |
| Not reported/unknown | 222 (29) |
| World Bank country income grouping | |
| High | 292 (39) |
| Upper middle and lower middle | 461 (61) |
Abbreviations: MSM-men who have sex with men; ART-antiretroviral therapy; NRTI-non-nucleoside reverse transcriptase inhibitors; NNRTI-non-nucleoside reverse transcriptase inhibitors; PI-protease inhibitors; INSTI-integrase strand transfer inhibitors; STIs-sexually transmitted infections.